The purpose of this study is to determine if a laboratory test developed by the Sequenom Center for Molecular Medicine (SCMM) that uses a new marker found in the mother's blood can better identify pregnancies that have a child with a chromosome abnormality such as Down syndrome (Trisomy 21), Edwards syndrome (Trisomy 18), or other chromosome abnormality.
Study Type
OBSERVATIONAL
Enrollment
5,000
One blood draw of 20 to 30 mL
Validate the prenatal aneuploidy LDT with blood samples from pregnant women who are undergoing invasive prenatal diagnosis
Time frame: During the 1st and 2nd trimester of pregnancy
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Desert Good Samaritan Hospital
Mesa, Arizona, United States
Banner Good Samaritan Hospital
Phoenix, Arizona, United States
Phoenix Perinatal Associates, Phoenix Arizona Clinic
Phoenix, Arizona, United States
Obstetric Perinatal Clinic Tucson (WOMB)
Tucson, Arizona, United States
Fetal Diagnostic Center
Laguna Hills, California, United States
Long Beach Memorial Medical Center - Magella Medical Group
Long Beach, California, United States
Obstetrix Medical Group of California - Hamilton
San Jose, California, United States
Obstetrix Medical Group - Colorado at Presbyterian/St. Luke's Center
Denver, Colorado, United States
Obstetrix Medical Group Colorado - Antepartum Testing Unit at Rose Medical Center
Denver, Colorado, United States
Obstetrix Medical Group Colorada - Perinatal Resource Center at Swedish Medical Center
Englewood, Colorado, United States
...and 15 more locations